Skip to main content
Klotho Neurosciences, Inc. logo

Klotho Neurosciences, Inc. — Investor Relations & Filings

Ticker · KLTO ISIN · US7580831094 US Manufacturing
Filings indexed 204 across all filing types
Latest filing 2025-11-13 Interim / Quarterly Rep…
Country US United States of America
Listing US KLTO

About Klotho Neurosciences, Inc.

https://klothoneuro.com/

Klotho Neurosciences, Inc. is a biopharmaceutical company focused on the development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders. The company develops treatments for conditions with high unmet medical needs, including amyotrophic lateral sclerosis (ALS), Alzheimer's, and Parkinson's disease. Its core approach involves pioneering gene and cell therapies that utilize DNA and RNA as therapeutics. A key area of its research is centered on genomic therapies targeting the alpha-Klotho gene, a known regulator of aging. The company's portfolio consists of proprietary cell and gene therapy programs designed to offer transformative outcomes for patients.

Recent filings

Filing Released Lang Actions
QUARTERLY REPORT
Interim / Quarterly Report Q3 2025
2025-11-13 English
REGISTRATION STATEMENT
Registration Form
2025-11-06 English
PROSPECTUS SUPPLEMENT
Prospectus
2025-09-30 English
PRIMARY DOCUMENT
Director's Dealing
2025-09-29 English
CURRENT REPORT
Regulatory Filings
2025-09-25 English
CURRENT REPORT
Regulatory Filings
2025-09-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.